Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has published its ‘Samsung Biologics ESG Report 2026’ on its official website, detailing its economic, environmental, and social ESG performance and quantitative metrics (ESG Factbook) for FY2025.
📊 [Key Disclosure Details & Financial Summary]
- Report Name: Samsung Biologics ESG Report 2026
- Submission Date: 2026-06-01
- Reporting Period: 2025-01-01 ~ 2025-12-31 (Includes key accomplishments up to the day prior to publication in 2026)
- Access Location: Samsung Biologics Official Website (https://samsungbiologics.com/kr/esg/resources)
- Reporting Standards & Verification:
- Reporting Standards: Prepared in accordance with GRI Standards 2021; referenced ISO 26000, UN Global Compact, Framework, SASB, ESRS, ISSB, KSSB (No. 1 & No. 2 Climate-related Disclosures), TCFD, and CDP recommendations
- Assurance Provider: BSI (British Standards Institution) Group Korea
- Assurance Standards & Level: Third-party verification conducted under AA1000AP(2018) and AA1000AS v3(2020) at Type 1 Moderate level
- Structure & Key Highlights:
- Report Structure: Management Report, Strategic Report, ESG Performance Report (Governance, Environmental, Social), and Appendix
- ESG Factbook Published: Quantitative metrics published separately as an ESG Factbook, containing 3-year historical data (2023–2025) to track trends (accessible via website ESG section)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Annual Changes in 2023–2025 Quantitative ESG Metrics via ESG Report and ESG Factbook
This filing is a voluntary disclosure to transparently communicate the company’s ESG performance to stakeholders. Reviewing the annual changes in quantitative ESG metrics and key accomplishments from 2023 to 2025 in the report and ESG Factbook is important for identifying the trends of disclosed performance. Detailed information can be verified in the Sustainability Report and ESG Factbook available on the official Samsung Biologics website under the ESG section.
📢 Disclaimer & Source Notice
Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Disclaimer: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest entirely with the investor.
Contact: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.
